Harneys, alongside Davis Polk & Wardwell and King & Wood Mallesons, acted as Cayman Islands counsel to CANbridge Pharmaceuticals Inc. Kirkland & Ellis and Tian Yuan...
CANbridge Pharmaceuticals Inc.’s HK$604 Million IPO
ANE (Cayman) Ltd.’s US$127 Million Listin On The HKSE
Freshfields Bruckhaus Deringer advised the joint sponsors and the underwriters in the global offering and listing of shares of ANE (Cayman) Inc. on the Hong Kong...
Yili Group’s HK$6.25 Billion Acquisition of 34.33% of Ausnutria Dairy
Davis Polk advised Inner Mongolia Yili Industrial Group on the deal. Inner Mongolia Yili Industrial Group Co., Ltd executed the acquisition of 34.33% of Ausnutria Dairy...
MicroTech Medical’s US$249 Million Initial Public Offering
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
Broncus Holding’s HK$1.55 Billion Initial Public Offering
Davis Polk, Gleiss Lutz and Maples and Calder advised Broncus Holding Corporation, while Dentons Hong Kong advised Goldman Sachs and Haitong International Capital in the transaction....
Kindstar Globalgene Technology’s US$285.2 Million IPO
S&C acted as Hong Kong and U.S. counsel to the joint sponsors and underwriters, including Goldman Sachs, CICC and Credit Suisse. Davis Polk advised Kindstar Globalgene...
Nayuki’s $655 Million Initial Public Offering
Kirkland & Ellis advised the sponsors and underwriters on the initial public offering of Nayuki Holdings Limited, assisted by Walkers and Davis Polk & Wardwell. Other...
Zylox-Tonbridge’s US$330 Million IPO and Listing on the Hong Kong Stock Exchange
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
CARsgen Therapeutics Holdings Limited’s Listing on the Stock Exchange of Hong Kong
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....
Zai Lab’s $857.5 Million Shares Offering
Davis Polk advised Zai Lab Limited in the deal, while Simpson Thacher represented the underwriters. Zai Lab Limited executed its offering of 5,492,400 American depositary shares,...
Zhejiang Expressway’s €230 Million Convertible Bonds Offering
Davis Polk advised Zhejiang Expressway on the deal. Zhejiang Expressway Co., Ltd. executed its Regulation S offering of €230 million zero coupon H Share convertible bonds...
JOINN Laboratories’ $844 Million Initial Public Offering
Davis Polk advised JOINN Laboratories on the deal while Sullivan & Cromwell LLP represented the sole sponsor and the underwriters. JOINN Laboratories (China) Co., Ltd. finalized...